Literature DB >> 9952216

Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis.

K M Das1.   

Abstract

Extraintestinal manifestations in patients with inflammatory bowel disease (IBD) are quite common (about 25%) and careful clinical observation and statistical analysis during the last five decades have demonstrated that in colitis-associated extraintestinal complications, the organs most commonly involved are the biliary tract, joints, skin, and eyes. However, almost all organs can be involved in IBD. Some of the extraintestinal manifestations may precede IBD, although the majority accompany the underlying disease and are influenced by its activity. Prompt recognition of extracolonic organ involvement in IBD is important because of the relative refractoriness of the disease and a possible increase in morbidity and mortality. The identified pathogenetic autoimmune mechanisms include genetic susceptibility, cytokine imbalances, antigenic display of autoantigen, aberrant self-recognition, and immunopathogenetic autoantibodies against organ-specific cellular antigen(s) shared by colon and extracolonic organs. Microbes may play an important role, probably by molecular mimicry.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9952216     DOI: 10.1023/a:1026629528233

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  111 in total

1.  Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis.

Authors:  T S Halstensen; T E Mollnes; P Garred; O Fausa; P Brandtzaeg
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

2.  Autoimmunity--towards the year 2001.

Authors:  N Yeatman; J Sachs; G F Bottazzo
Journal:  Immunol Today       Date:  1992-07

3.  ABNORMALITIES OF THE SACRO-ILIAC JOINTS AND UVEITIS IN ULCERATIVE COLITIS.

Authors:  R WRIGHT; K LUMSDEN; M H LUNTZ; D SEVEL; S C TRUELOVE
Journal:  Q J Med       Date:  1965-04

4.  Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.

Authors:  F Seibold; P Weber; R Klein; P A Berg; K H Wiedmann
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

Review 5.  Cutaneous manifestations of gastrointestinal disorders. Part II.

Authors:  B Gregory; V C Ho
Journal:  J Am Acad Dermatol       Date:  1992-03       Impact factor: 11.527

6.  A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody.

Authors:  K M Das; M Vecchi; S Sakamaki
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

7.  Epithelial deposition of immunoglobulin G1 and activated complement (C3b and terminal complement complex) in ulcerative colitis.

Authors:  T S Halstensen; T E Mollnes; P Garred; O Fausa; P Brandtzaeg
Journal:  Gastroenterology       Date:  1990-05       Impact factor: 22.682

8.  Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis.

Authors:  C M Weyand; C Xie; J J Goronzy
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

9.  Autoantibodies in human ulcerative colitis.

Authors:  O BROBERGER; P PERLMANN
Journal:  J Exp Med       Date:  1959-11-01       Impact factor: 14.307

10.  In vitro studies of ulcerative colitis. I. Reactions of patients' serum with human fetal colon cells in tissue cultures.

Authors:  O BROBERGER; P PERLMANN
Journal:  J Exp Med       Date:  1963-05-01       Impact factor: 14.307

View more
  51 in total

Review 1.  Clinical aspects and pathophysiology of inflammatory bowel disease.

Authors:  Barbara A Hendrickson; Ranjana Gokhale; Judy H Cho
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

2.  Linear IgA bullous dermatosis: an association with ulcerative colitis versus renal cell carcinoma.

Authors:  A Scott Keller; Molly B Bouldin; Lisa A Drage; Stephen C Hauser; Mark D P Davis
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

3.  Arthritis or vasculitis as presenting symptoms of Crohn's disease.

Authors:  Reuven Mader; Ori Segol; Muhammed Adawi; Philippe Trougoboff; Elchanan Nussinson
Journal:  Rheumatol Int       Date:  2004-04-20       Impact factor: 2.631

4.  Autoantibodies pANCA, GAB and PAB in inflammatory bowel disease: prevalence, characteristics and diagnostic value.

Authors:  Evgenija Homsak; Dusanka Micetić-Turk; Borut Bozic
Journal:  Wien Klin Wochenschr       Date:  2010-05       Impact factor: 1.704

5.  Ocular Manifestations in Inflammatory Bowel Disease Are Associated with Other Extra-intestinal Manifestations, Gender, and Genes Implicated in Other Immune-related Traits.

Authors:  Sasha Taleban; Dalin Li; Stephan R Targan; Andrew Ippoliti; Steven R Brant; Judy H Cho; Richard H Duerr; John D Rioux; Mark S Silverberg; Eric A Vasiliauskas; Jerome I Rotter; Talin Haritunians; David Q Shih; Marla Dubinsky; Gil Y Melmed; Dermot P B McGovern
Journal:  J Crohns Colitis       Date:  2015-10-08       Impact factor: 9.071

6.  Association between maternal inflammatory bowel disease and adverse perinatal outcomes.

Authors:  D Getahun; M J Fassett; G F Longstreth; C Koebnick; A M Langer-Gould; D Strickland; S J Jacobsen
Journal:  J Perinatol       Date:  2014-03-20       Impact factor: 2.521

7.  IgA nephropathy in association with Crohn's disease.

Authors:  M J Forshaw; O Guirguis; T W Hennigan
Journal:  Int J Colorectal Dis       Date:  2005-01-25       Impact factor: 2.571

8.  Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: Frequency and relation with disease phenotype.

Authors:  Bikramjit Singh; Saurabh Kedia; Gauree Konijeti; Venigalla Pratap Mouli; Rajan Dhingra; Lalit Kurrey; Saurabh Srivastava; Rajesh Pradhan; Govind Makharia; Vineet Ahuja
Journal:  Indian J Gastroenterol       Date:  2015-02-07

9.  Ulcerative colitis-associated pulmonary nodules with cavity formation successfully treated with mesalazine and granulocyte-monocyte apheresis.

Authors:  Hiroaki Nomoto; Yoshikazu Hayashi; Satoshi Shinozaki; Tomonori Yano; Keijiro Sunada; Wataru Sasao; Aya Kitamura; Mai Ohashi; Shuhei Hiyama; Alan Kawarai Lefor; Hironori Yamamoto
Journal:  Clin J Gastroenterol       Date:  2014-10-07

10.  Inflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (MUC1) links inflammatory bowel disease and pancreatitis.

Authors:  Deepak K Kadayakkara; Pamela L Beatty; Michael S Turner; Jelena M Janjic; Eric T Ahrens; Olivera J Finn
Journal:  Pancreas       Date:  2010-05       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.